Tower Research Capital LLC (Trc) Maia Biotechnology, Inc. Transaction History
Tower Research Capital LLC (Trc)
- $4.87 Billion
- Q4 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Maia Biotechnology, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 3,285 shares of MAIA stock, worth $6,175. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,285
Previous 1,466
124.08%
Holding current value
$6,175
Previous $4,000
50.0%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding MAIA
# of Institutions
19Shares Held
1.38MCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA583KShares$1.1 Million0.0% of portfolio
-
Halter Ferguson Financial Inc. Carmel, IN241KShares$452,7370.2% of portfolio
-
Geode Capital Management, LLC Boston, MA198KShares$371,3450.0% of portfolio
-
Black Rock Inc. New York, NY78.5KShares$147,6190.0% of portfolio
-
Centric Wealth Management68.2KShares$128,2510.04% of portfolio
About MAIA Biotechnology, Inc.
- Ticker MAIA
- Exchange
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 10,935,900
- Market Cap $20.6M
- Description
- MAIA Biotechnology, Inc., a clinical stage biotechnology company, engages in the discovery, development, and commercialization of therapies targeting cancer, primarily non-small cell lung cancer. Its lead asset, THIO, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. The company wa...